TEMPE, Ariz., Sept. 12, 2024 /PRNewswire/ — GT Medical Technologies, Inc. (“GT MedTech” or the “Company”), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced it has secured a $35 million venture loan facility, of which $15 million has been initially funded from Horizon Technology Finance Corporation (NASDAQ: HRZN), an affiliate of Monroe Capital.Continue reading
Category Archives: AZBio News
TGen launches Center for Spatial Multi-Omics (COSMO): A Service Center dedicated to transforming biomedical research through spatial biology
PHOENIX, AZ (September 11, 2024) – The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of the Center for Spatial Multi-Omics (COSMO), a service center dedicated to transforming biomedical research through spatial biology. COSMO offers an unparalleled suite of services designed to help scientists visualize and map molecular data at the single-cell level directly within tissues.Continue reading
FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson’s and Related Diseases
- U.S. regulatory agency recognizes potential of alpha-synuclein seed amplification assay (αSyn-SAA) to accelerate clear outcomes in drugmakers’ trials
- Letter is latest milestone in the journey of the biomarker, discovered in 2023, to transform drug development focused on synuclein pathology — a biological hallmark of Parkinson’s, Dementia with Lewy Bodies and related neurodegenerative conditions
- FDA notes critical role of the Parkinson’s Progression Markers Initiative in generating and validating data and studies that made this landmark step forward possible
BIO5 Institute’s Kelle Hyland honored as 2024 AZBio Bioscience Educator of the Year
An integral part of the BIO5 Institute’s KEYS Research Internship program for the past 8 years, Kelle Hyland has been recognized for her extraordinary leadership and dedication by the Arizona Bioindustry Association.Continue reading
AZBioPEERS Video: Preparing for Investor Success
This AZBioPEERS webinar is presented by Richard Kovacik, JD, MBA, Managing Director of the Healthcare Growth Group. The program is designed to equip life science startups with an overview of the most important knowledge and considerations needed to attract and engage investors.Continue reading
Applications Open for ABRC Investigator Grants
The Arizona Biomedical Research Centre (ABRC) of the Arizona Department of Health Services is soliciting grant proposals for RFGA2024-022 Arizona Investigator Grant (AZ IG) or New Investigator Awards (NIA).
This is a two-phased application process. Approximately $10,5000,000 is available for biomedical grant projects over a period of three (3) years.
C-Path Announces FDA Commissioner Robert Califf to Participate in Opening Session at Inaugural Global Impact Conference
#CGIC24 Registration Nears Capacity; Closes Saturday, Aug. 31Continue reading
Multi-year, 1143-patient genetic study identifies unique types of multiple myeloma
TGen-led group confirms high-risk subgroup among cancer patientsContinue reading
C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund at Notre Dame to Enhance Collaboration in Niemann-Pick Disease Research and Drug Development
TUCSON, Ariz., August 22, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Critical Path for Lysosomal Diseases (CPLD) Consortium has been awarded a grant from the Ara Parseghian Medical Research Fund (APMRF) at the University of Notre Dame.Continue reading